Dr. Peng's Research and Studies Published in Medical Journals: (from 2016 till now )

Antiepileptic drug optimization using ambulatory electrocorticographic data from an implanted brain‐responsive neurostimulator

Clinical Case Reports

2020-01-30 | journal-article

 SREAT presenting as decades of intractable seizures and isolated delusional episodes with clinical, laboratory and EEG-confirmation of treatment response

SAGE Open Medical Case Reports

2019-05 | journal-article

DOI: 10.1177/2050313X19850051


Gastrointestinal Beriberi and Wernicke’s Encephalopathy Triggered by One Session of Heavy Drinking

Case Reports in Neurology

2019-04-18 | journal-article

DOI: 10.1159/000499601

Part of ISSN: 1662-680X


Reversible hand tremors, downbeat nystagmus, and an unsteady gait with nontoxic lithium level

Clinical Case Reports

2019-01-24 | journal-article

DOI: 10.1002/ccr3.1981

PMID: 30899510


Small-cell lung carcinoma and acute onset of antiglial nuclear antibody-positive limbic encephalitis

Clinical Case Reports

2017-03-08 | journal-article

DOI: 10.1002/ccr3.894

PMID: 28396782


Reversible dementia: subclinical seizure in early-onset dementia

Clinical Case Reports

2017-02-06 | journal-article

DOI: 10.1002/ccr3.843

PMID: 28265399


Hashimoto's encephalopathy - presenting with epilepsia partialis continua and a frontal lobe lesion

Clinical Case Reports

2017 | journal-article

DOI: 10.1002/ccr3.1306

PMID: 29375853


Correlations of Clusters of Non-Convulsive Seizure and Magnetic Resonance Imaging in a Case With GAD65-Positive Autoimmune Limbic Encephalitis

Journal of Clinical Medicine Research

2016 | journal-article

DOI: 10.14740/jocmr2624w

PMID: 27429684

Peggie Smith's Publications and Research  


Elizabeth Zauber, Peggie A. Smith and Leo Verhagen (2011), Fundamentals of Deep Brain Stimulation Programming in William J. Marks, Jr. (Ed.), Deep Brain Stimulation Management (pp. 43-56). Cambridge University Press


ACT Study: Botox Purified Neurotoxin Complex as Headache Prophylaxis in Adolescents (Children 12 to <18 years of age) with Chronic Migraine.  Protocol No.: 191622-103.  Sub-Investigator


ALD403-006   PROMISE STUDY: Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients with Frequent Episodic Migraines.  Protocol No.:ALD403-CLIN-00., Sub-Investigator


Amgen 334 20120295 A double blind placebo controlled trial to evaluate the safety and efficacy of AMG334 in chronic Migraine Prevention.  Protocol No.: AMG334 20120295.  Sub-Investigator

APEX Study:  Multicenter, Randomized, Active-Controlled Efficacy and Safety Study Comparing Extended Duration Betrixaban with Standard of Care Enoxaparin for the Prevention of Venous Thromboembolism in Acute Medically Ill Patients.  Protocol Number 11-019. Sub-Investigator and Study Coordinator


Ceregene: A Trial Assessing the Safety and Efficacy of Bilateral Intraputaminal and Intranigral Administration of CERE-120 Adeno-Associated Virus Serotype 2 [AAV2] - Neurturin in Subjects with Idiopathic Parkinson’s Disease. Protocol No. CERE 120 and CERE 120-09. Study Coordinator


The CHAMP Study: Amitriptyline and Topiramate in the Prevention of Childhood Migraine.  IND #112,220; Sub-Investigator and Study


DALF-PS-1016:  Double-Blind, Placebo-Controlled, parallel-Group Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets for Treatment of Stable Walking Deficits in Post-Ischemic Stroke (MILESTONE).  Protocol No.: DALF-PS-1016.  Sub-Investigator


GMA-US-NEU-0206:  FORWARD Study: A multicenter, proscpective, randomized, open-label study to compare the efficacy, safety, and tolerability of BOTOX and Topiramate for Headache Prophylaxis in Adults with Chronic Migraine.  Protocol No.: GMA-US-NEU-0206.  Sub-Investigator


PRISMS: Phase IIIb, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Alteplase in Patients with Mild Stroke: Rapidly Improving Symptoms and Minor Neurologic Deficits. Protocol Number: ML29093. Sub-Investigator and Study Coordinator


RESPECT-ESUS:  Randomized, double-blind, evaluation in secondary stroke prevention comparing the efficacy and safety of the oral thrombin inhibitor dabigatran etexilate (110mg or 150 mg oral BID) versus acetylsalicylic acid (100mg oral q.d.) in patients with embolic stroke of undetermined source.  Protocol No. 1160.189.  Sub-Investigator



Spheramine:  Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally into the Postcommissural Putamen of Patients with Advanced Parkinson’s Disease.  Study Coordinator

🚑     Amity Neurology

          236 W. 6th St., Suite 401

          Reno, NV 89503

Call : (775) 432-6189

Fax:  (775) 284-5625

  • Facebook Social Icon
For Life-Threatening Emergencies Call 911

© 2019 by Amity Neurology.  All rights reserved.